Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepatitis B Vaccine Response in Chronic HCV Patients
NCT02898922Phase 4Completed
- Sponsor
- Shandong Provincial Center for Disease Control and Prevention
- Start
- Jun 2013
- Primary completion
- Jan 2015
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
01
Overview
A Phase 4 trial of Hepatitis B vaccine in hepatitis B (HBV), sponsored by Shandong Provincial Center for Disease Control and Prevention. Started Jun 2013; status: completed.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT02898922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02898922.